Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aphria Inc. APHA

Healthcare Drug Manufacturers - Major Cannabis
Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints of federal prohibition. It has some U.S. exposure through the acquisition of SweetWater, a craft brewer


NDAQ:APHA - Post by User

Aphria Inc.
Bullboard Posts
User Avatar Image
(88)
•••
Comment by INVSTIGAT0Ron Jul 19, 2019 7:32am
201 Views
Post# 29938538

RE:RE:RE:Wow!!

RE:RE:RE:Wow!!I'd like to know why any of you are speculating ACT II in a positive manner. It may or may not be at all related to Aphria and if it is? It's separate, which means if it were to become a part of Aphria, shareholders of Aphria would be the ones paying for it. Is Irwin going to let ACT II become part of Aphria at cost? Or will it just be another shell type entity flipped to Aphria for more money yet again? Someone explain how ACT II is at all beneficial please. It's not part of Aphria and the 300k is not our money. If ACT II isn't at all part of the Aphria plan then what the hell is Irwin doing with his time?
Bullboard Posts
Dealroom for high-potential pre-IPO opportunities